A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions
Hyperkalaemia
Trial Locations (27)

Unknown

Research Site, Anshan

Research Site, Beijing

Research Site, Benxi

Research Site, Changsha

Research Site, Changshu

Research Site, Chengdu

Research Site, Dalian

Research Site, Guangzhou

Research Site, Handan

Research Site, Hangzhou

Research Site, Hefei

Research Site, Hohhot

Research Site, Jiaxing

Research Site, Kunshan

Research Site, Linfen

Research Site, Nanjing

Research Site, Nanyang

Research Site, Ningbo

Research Site, Qidong

Research Site, Shijiazhuang

Research Site, Shiyan

Research Site, Taian

Research Site, Taishing

Research Site, Tianjin

Research Site, Wenzhou

Research Site, Xi'an

Research Site, Xinghua

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY